A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is
Background. Atopic Dermatitis (AD) is a common, chronic skin disorder caused by complex genetic, immunological, and environmental interactions. The current standard treatments for AD are improvable with a low efficiency, particularly in severe cases. Using well characterized molecules the "Ignacio Umbert Dermatology Institute" (IUDI) has developed topical treatments differentiated from the standards (European patent number EP2311454). Objective. Evaluate the therapeutic efficacy of EP2311454doi:10.11138/cderm/2017.5.1.005 fatcat:dwtqxxminbh2nl2vj4vs4aikgy